BioVie是一家临床阶段的生物制药公司,...查看全文
chuminhua2023-11-30 20:57
11/29,BioVie $BioVie(BIVI)$ 的股价周三暴跌 63%,此前该公司报告称,由于某些试验site的问题,评估其实验性阿尔茨海默病治疗药物 NE3107 的 III 期试验的主要终点未能达到统计显著性。 然而,该公司认为,来自可评估患者的数据表明所提议的疗法具有潜在的疗效优势,该疗法是一种结合细胞外信号...查看全文
美通社2022-11-22 15:58
天演药业宣布任命Cuong Do先生,MBA,为天演董事会的独立董事以及审计委员会成员。Do先生现为临床阶段公司BioVie Inc.的总裁兼CEO。入职BioVie前,Do先生曾担任三星全球战略集团总裁。他还曾担任默沙东公司的首席战略官。(医药健闻)查看全文
港美情报站2022-09-28 21:32
#美股# 开盘:三大股指开盘涨跌不一,$道琼斯指数(.DJI)$ 涨0.35%。$苹果(AAPL)$ 跌近3%,有报道称苹果公司撤销于今年增产#iPhone14# 的计划,原因是需求放缓。阿尔茨海默病概念股表现强势,渤健暴涨逾43%,此前公司宣布其实验性阿尔茨海默病药物lecanemab的三期临床试验结果积极;BioVie涨逾6%。查看全文
蹊之美股生物医药2021-08-10 20:25
作者:林出
微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
Liminal BioSciences (NASDAQ:LMNL) +27%
Allied Healthcare Products (NASDAQ:AHPI) +22%
SCWorx (NASDAQ:WORX) +18%
\NRx Pharmaceuticals (NASDAQ:NRXP) +14%
Windtree Therap...查看全文
$BIOVIE INC(BIVI)$ S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933 Filed: 2019-11-01 AccNo: 0001520138-19-000418 Size: 3 MB 网页链接
$BIOVIE INC(BIVI)$ CERT - Filed: 2019-10-18 AccNo: 0001354457-19-000534 Size: 86 KB 网页链接
$BIOVIE INC(BIVI)$ 8-K - Current report Filed: 2019-10-09 AccNo: 0001520138-19-000379 Size: 210 KBItem 1.01: Entry into a Material Definitive AgreementItem 3.02: Unregistered Sales of Equity SecuritiesItem 3.03: Material Modifications to Rights of Security HoldersItem 9.01: F...
$BIOVIE INC(BIVI)$ S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933 Filed: 2019-10-09 AccNo: 0001520138-19-000382 Size: 1 MB 网页链接
$BIOVIE INC(BIVI)$ S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933 Filed: 2019-10-04 AccNo: 0001520138-19-000374 Size: 1 MB 网页链接
$BIOVIE INC(BIVI)$ S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933 Filed: 2019-10-02 AccNo: 0001520138-19-000360 Size: 1 MB 网页链接
$BIOVIE INC(BIVI)$ 8-A12B/A [Amend] - Registration of securities [Section 12(b)] Filed: 2019-10-02 AccNo: 0001520138-19-000365 Size: 16 KB 网页链接
$BIOVIE INC(BIVI)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2019-09-27 AccNo: 0001520138-19-000336 Size: 2 MB 网页链接
$BIOVIE INC(BIVI)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2019-09-25 AccNo: 0001437749-19-019024 Size: 77 KB 网页链接
$BIOVIE INC(BIVI)$ 8-K - Current report Filed: 2019-09-25 AccNo: 0001520138-19-000330 Size: 430 KBItem 1.01: Entry into a Material Definitive AgreementItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a RegistrantI...